Overview

The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The Guangdong work group of childhood acute lymphoblastic leukemia (ALL) therapy was set up in October 2002. The investigators treated the childhood ALL with a GZ2002 protocol since the year 2002, and the protocol was mainly derived from the ALLIC-BFM 2002 protocol. After summarizing the last six years' experience, our group revised the GZ2002 ALL protocol in the year 2008, which is named GD-2008 ALL protocol. The diagnosis and classified criteria is according to the ALLIC-BFM 2002 protocol, and the chemotherapy protocol consists all the therapeutic phases as the ALLIC-BFM 2002 protocol prescribed.
Phase:
Phase 4
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
6-Mercaptopurine
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Mercaptopurine
Methotrexate
Vincristine